Hrt Financial LP Eli Lilly & CO Transaction History

Hrt Financial LP

$17 Billion
Q2 2024

A detailed history of Hrt Financial LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Hrt Financial LP holds 1,798 shares of LLY stock, worth $1.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,798

Previous 15,829 88.64%

Holding current value

$1.58 Million

Previous $12.3 Million 86.79%

% of portfolio

0.01%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $10.2 Million - $12.8 Million	-14,031 Reduced 88.64%	1,798 $1.63 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $5.83 Million - $7.8 Million	-9,846 Reduced 38.35%	15,829 $12.3 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $6.56 Million - $7.73 Million	12,487 Added 94.68%	25,675 $15 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $5.01 Million - $6.91 Million	11,526 Added 693.5%	13,188 $7.08 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $114 Million - $152 Million	-324,175 Reduced 99.49%	1,662 $779,000
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $99.5 Million - $117 Million	320,334 Added 5821.08%	325,837 $112 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $1.77 Million - $2.06 Million	5,503 New	5,503 $2.01 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $14.6 Million - $17.2 Million	52,549 New	52,549 $17 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $5.67 Million - $7.04 Million	-25,229 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $6.92 Million - $8.52 Million	-31,248 Reduced 55.33%	25,229 $5.83 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $7.73 Million - $10 Million	42,832 Added 313.9%	56,477 $13 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $2.24 Million - $2.9 Million	13,645 New	13,645 $2.55 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $22.1 Million - $29.2 Million	-169,352 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $24.8 Million - $28.6 Million	169,352 New	169,352 $25.1 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $347,917 - $430,927	-3,254 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $102,625 - $111,629	961 Added 41.91%	3,254 $363,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $254,041 - $296,530	2,293 New	2,293 $254,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $3.15 Million - $3.71 Million	-28,290 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$105.9 - $118.64 $3 Million - $3.36 Million	28,290 New	28,290 $3.27 Million
Q2 2018 Aug 15, 2018	SELL	$75.7 - $86.88 $1.19 Million - $1.37 Million	-15,748 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $946,029 - $1.12 Million	12,748 Added 424.93%	15,748 $1.22 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $245,820 - $263,670	3,000	3,000 $253,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account